This company has been marked as potentially delisted and may not be actively trading. Tenzing Acquisition (TZAC) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock TZAC vs. NRBO, BFRG, MIRA, LPTX, BCTX, LSB, BIVI, NRSN, GLYC, and PHIOShould you be buying Tenzing Acquisition stock or one of its competitors? The main competitors of Tenzing Acquisition include NeuroBo Pharmaceuticals (NRBO), Bullfrog AI (BFRG), MIRA Pharmaceuticals (MIRA), Leap Therapeutics (LPTX), BriaCell Therapeutics (BCTX), Lakeshore Biopharma (LSB), BioVie (BIVI), NeuroSense Therapeutics (NRSN), GlycoMimetics (GLYC), and Phio Pharmaceuticals (PHIO). Tenzing Acquisition vs. NeuroBo Pharmaceuticals Bullfrog AI MIRA Pharmaceuticals Leap Therapeutics BriaCell Therapeutics Lakeshore Biopharma BioVie NeuroSense Therapeutics GlycoMimetics Phio Pharmaceuticals NeuroBo Pharmaceuticals (NASDAQ:NRBO) and Tenzing Acquisition (NASDAQ:TZAC) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, community ranking, earnings, dividends, institutional ownership, analyst recommendations, risk, media sentiment and profitability. Do analysts recommend NRBO or TZAC? NeuroBo Pharmaceuticals presently has a consensus price target of $10.00, indicating a potential upside of 1,076.47%. Given NeuroBo Pharmaceuticals' stronger consensus rating and higher possible upside, research analysts plainly believe NeuroBo Pharmaceuticals is more favorable than Tenzing Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NeuroBo Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Tenzing Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has better valuation and earnings, NRBO or TZAC? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeuroBo PharmaceuticalsN/AN/A-$12.47MN/AN/ATenzing AcquisitionN/AN/A$620KN/AN/A Is NRBO or TZAC more profitable? Tenzing Acquisition's return on equity of -13.32% beat NeuroBo Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets NeuroBo PharmaceuticalsN/A -189.12% -122.31% Tenzing Acquisition N/A -13.32%-1.36% Does the MarketBeat Community prefer NRBO or TZAC? NeuroBo Pharmaceuticals received 27 more outperform votes than Tenzing Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformNeuroBo PharmaceuticalsOutperform Votes2775.00% Underperform Votes925.00% Tenzing AcquisitionN/AN/A Which has more risk & volatility, NRBO or TZAC? NeuroBo Pharmaceuticals has a beta of -0.26, indicating that its share price is 126% less volatile than the S&P 500. Comparatively, Tenzing Acquisition has a beta of 0.01, indicating that its share price is 99% less volatile than the S&P 500. Do insiders & institutionals have more ownership in NRBO or TZAC? 1.4% of NeuroBo Pharmaceuticals shares are owned by institutional investors. Comparatively, 60.9% of Tenzing Acquisition shares are owned by institutional investors. 1.1% of NeuroBo Pharmaceuticals shares are owned by company insiders. Comparatively, 37.5% of Tenzing Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media prefer NRBO or TZAC? In the previous week, NeuroBo Pharmaceuticals' average media sentiment score of 0.00 equaled Tenzing Acquisition'saverage media sentiment score. Company Overall Sentiment NeuroBo Pharmaceuticals Neutral Tenzing Acquisition Neutral SummaryTenzing Acquisition beats NeuroBo Pharmaceuticals on 6 of the 10 factors compared between the two stocks. Get Tenzing Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for TZAC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TZAC vs. The Competition Export to ExcelMetricTenzing AcquisitionPharmaceutical Preparations Industry SectorNASDAQ ExchangeMarket Cap$4.38M$6.68B$2.41B$7.80BDividend YieldN/A3.17%13.22%4.30%P/E RatioN/A7.1410.7718.40Price / SalesN/A238.893,504,142.39101.29Price / Cash143.1065.6754.9934.62Price / Book0.876.263.194.18Net Income$620,000.00$142.48M-$305.73M$247.71M Tenzing Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TZACTenzing AcquisitionN/A$0.86-5.0%N/A-70.2%$4.38MN/A0.00N/AHigh Trading VolumeNRBONeuroBo PharmaceuticalsN/A$1.84+26.9%$10.00+443.5%-72.2%$15.85MN/A0.0010High Trading VolumeBFRGBullfrog AI0.6442 of 5 stars$1.63-8.9%N/A-35.3%$15.35M$60,000.00-1.924MIRAMIRA Pharmaceuticals2.3289 of 5 stars$0.90+0.6%$14.00+1,464.1%+15.6%$15.05MN/A-1.602Positive NewsLPTXLeap Therapeutics1.8748 of 5 stars$0.36+6.4%$4.92+1,255.6%-87.4%$14.96MN/A-0.1940BCTXBriaCell Therapeutics1.5772 of 5 stars$4.00-8.7%$32.00+700.0%-84.5%$14.84MN/A-0.308Analyst ForecastAnalyst RevisionNews CoverageGap DownLSBLakeshore Biopharma0.2735 of 5 stars$1.59-9.6%N/AN/A$14.80M$672.27M0.00773Gap UpBIVIBioVie1.8973 of 5 stars$0.80-8.0%$3.00+277.4%+71.8%$14.67MN/A-0.0810Positive NewsGap DownNRSNNeuroSense Therapeutics0.5925 of 5 stars$1.07-1.3%N/A-20.6%$14.57MN/A-1.6710News CoverageGLYCGlycoMimetics1.7925 of 5 stars$0.23+1.4%N/A-84.7%$14.52M$10,000.000.0050Analyst ForecastNews CoveragePHIOPhio Pharmaceuticals2.9178 of 5 stars$2.93+33.2%$4.00+36.5%-67.9%$14MN/A-0.2710 Related Companies and Tools Related Companies NeuroBo Pharmaceuticals Competitors Bullfrog AI Competitors MIRA Pharmaceuticals Competitors Leap Therapeutics Competitors BriaCell Therapeutics Competitors Lakeshore Biopharma Competitors BioVie Competitors NeuroSense Therapeutics Competitors GlycoMimetics Competitors Phio Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TZAC) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tenzing Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tenzing Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TZAC Stock Free TZAC Stock Alerts